| Kyle A O'donnell, RPA-C | |
|
2675 N Decatur Rd Ste 512, Decatur, GA 30033-6134 | |
| (470) 223-4707 | |
| (404) 501-7062 |
| Full Name | Kyle A O'donnell |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2675 N Decatur Rd Ste 512, Decatur, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801149612 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 015983 (New York) | Secondary |
| 363A00000X | Physician Assistant | 7586 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kyle A O'donnell, RPA-C 2675 N Decatur Rd Ste 512, Decatur, GA 30033-6134 Ph: (470) 223-4707 | Kyle A O'donnell, RPA-C 2675 N Decatur Rd Ste 512, Decatur, GA 30033-6134 Ph: (470) 223-4707 |
News Archive
Cancer Research Technology Limited (CRT), the specialist oncology focussed technology transfer and development company, today announced the completion of a Technology Transfer Agreement with Marie Curie Cancer Care, one of the largest cancer charities in the UK.
EntreMed, Inc. today announced the initiation of a multi-center Phase 2 study with its lead oncology product candidate, ENMD-2076, in patients with platinum resistant ovarian cancer. The study will be conducted at up to six sites in the United States and Canada. In addition, EntreMed received a No Objection Letter (NOL) from the Therapeutic Products Directorate of Health Canada on its Clinical Trial Application to conduct the Phase 2 clinical trial in ovarian cancer patients.
New studies this week suggest that more Americans will suffer a disability that threatens their independence near the end of their lives.
OraSure Technologies, Inc. announced today that its OraQuick Hepatitis C Rapid Antibody Test has been approved by the U.S. Food and Drug Administration for use in detecting HCV antibodies in venous whole blood specimens, making it the first rapid HCV test approved by the FDA for use in the United States.
Emisphere Technologies, Inc. today announced that a clinical study found that the company's proprietary oral SNAC (Sodium N-[8-(2-hydroxybenzoyl) Amino] Caprylate ("SNAC") additive, in combination with two digestive hormones, was successful in reducing food intake and increasing satiety in healthy male subjects.
› Verified 8 days ago
Mr. Ronald Gene Sanders Ii, RONALD SANDERS Physician Assistant Medicare: Medicare Enrolled Practice Location: 4325 Old Lake Dr, Decatur, GA 30034 Phone: 770-843-0929 | |
Ms. Carol T Mcclendon, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 404-321-6111 | |
Rhea V Douglas, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1951 Clairmont Rd, Decatur, GA 30033 Phone: 404-321-4600 Fax: 404-320-0987 | |
Allyson Ashton, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2701 N Decatur Rd, Decatur, GA 30033 Phone: 404-501-1000 | |
Mrs. Daviea Antoinette Taylor-hicks, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 250 N Arcadia Ave, Decatur, GA 30030 Phone: 404-321-6111 Fax: 404-417-2903 | |
Amanda Singh, M.P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2675 N Decatur Rd, Decatur, GA 30033 Phone: 404-299-1678 | |
Theresa Ann Johnson, PHD, MSHSA, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1670 Clairmont Rd, Decatur, GA 30033 Phone: 404-321-6111 Fax: 404-417-1525 |